tradingkey.logo
tradingkey.logo
Pesquisar

LeMaitre Vascular Inc

LMAT
Adicionar à lista de desejos
98.740USD
+2.780+2.90%
Fechamento 07/01, 16:00ETCotações atrasadas em 15 min
2.25BValor de mercado
35.90P/L TTM

Mais detalhes de LeMaitre Vascular Inc Empresa

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.

Informações de LeMaitre Vascular Inc

Código da empresaLMAT
Nome da EmpresaLeMaitre Vascular Inc
Data de listagemOct 19, 2006
CEOLemaitre (George W)
Número de funcionários651
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 19
Endereço63 2nd Ave
CidadeBURLINGTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01803
Telefone17812212266
Sitehttps://www.lemaitre.com/
Código da empresaLMAT
Data de listagemOct 19, 2006
CEOLemaitre (George W)

Executivos da empresa LeMaitre Vascular Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David Brian (Dave) Roberts
Mr. David Brian (Dave) Roberts
President, Director
President, Director
6.68K
-108.68%
Mr. Lawrence J. (Larry) Jasinski
Mr. Lawrence J. (Larry) Jasinski
Independent Director
Independent Director
3.19K
-33.98%
Mr. Trent G. Kamke
Mr. Trent G. Kamke
Senior Vice President - Operations
Senior Vice President - Operations
2.24K
-198.61%
Ms. Martha Shadan
Ms. Martha Shadan
Independent Director
Independent Director
1.44K
-105.55%
Mr. George W. Lemaitre
Mr. George W. Lemaitre
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Joseph P. Pellegrino, Jr.
Mr. Joseph P. Pellegrino, Jr.
Director
Director
--
--
Mr. John J. O'Connor
Mr. John J. O'Connor
Independent Director
Independent Director
--
--
Ms. Kimberly L. Cieslak
Ms. Kimberly L. Cieslak
Vice President - Marketing
Vice President - Marketing
--
--
Mr. Ryan H. Connelly
Mr. Ryan H. Connelly
Senior Vice President - Advanced Manufacturing Engineering
Senior Vice President - Advanced Manufacturing Engineering
--
--
Mr. Maik D. Helmers
Mr. Maik D. Helmers
Senior Vice President - Sales, Central Europe
Senior Vice President - Sales, Central Europe
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David Brian (Dave) Roberts
Mr. David Brian (Dave) Roberts
President, Director
President, Director
6.68K
-108.68%
Mr. Lawrence J. (Larry) Jasinski
Mr. Lawrence J. (Larry) Jasinski
Independent Director
Independent Director
3.19K
-33.98%
Mr. Trent G. Kamke
Mr. Trent G. Kamke
Senior Vice President - Operations
Senior Vice President - Operations
2.24K
-198.61%
Ms. Martha Shadan
Ms. Martha Shadan
Independent Director
Independent Director
1.44K
-105.55%
Mr. George W. Lemaitre
Mr. George W. Lemaitre
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Joseph P. Pellegrino, Jr.
Mr. Joseph P. Pellegrino, Jr.
Director
Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de LeMaitre Vascular Inc?

Os cinco principais acionistas de LeMaitre Vascular Inc são: Mr. David Brian (Dave) Roberts

Quantas instituições possuem ações da LeMaitre Vascular Inc (LMAT)?

Em 2026Q1, 614 instituições possuíam ações da LeMaitre Vascular Inc, com valor de mercado aproximado de 23.53M, representando 102.98% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 853773.00.